Page 13 - Fabio Chianelli News Today : Breaking News, Live Updates & Top Stories | Vimarsana

PharmaTher Holdings Announces FDA Grant of Orphan Drug

PharmaTher’s 5th FDA orphan drug designation for KETARX™ (ketamine) Phase 2 clinical study results to support proposed Phase 3 development of KETARX™.

Fabio chianelliPharmather holdings ltdRett syndrome foundationCompany or pharmatherDrug administrationRett syndromeMother holdingsStatus epilepticusAmyotrophic lateral sclerosisComplex regional painCanadian stock exchange phrm cnPharmather holdings ltdDrug designation

DiagnaMed Holdings Incorporates OpenAI s ChatGPT into BRAIN AGE™ AI Product Suite

DiagnaMed Holdings Incorporates OpenAI s ChatGPT into BRAIN AGE™ AI Product Suite
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Fabio chianelliOur brain health digital platformNeither the canadian securities exchangeBrain health platformDiagnamed brain health digital platformDiagnamed holdings corpRegulation services providerBrain health digital platformMed holdingsArtificial intelligenceProduct suiteBoarddiagnamed holdings corp telCanadian securities exchangeDiagnamed holdings

DiagnaMed Holdings Provides Update for BRAIN AGE Development and Commercialization Milestones for 2023

31.01.2023 - Complete IRB-approved research study in Q2-2023 Commercialize BRAIN AGE in Q4-2023 TORONTO, Jan. 31, 2023 (GLOBE NEWSWIRE) - DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED), an artificial intelligence-driven digital . Seite 1

John kouniosFabio chianelliDrexel universityBrain sciences at drexel universityBrain sciences

PharmaTher Holdings Submits for FDA Orphan Drug Designation

TORONTO, Jan. 18, 2023 (GLOBE NEWSWIRE) PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a leader in specialty.

United statesFabio chianelliDavidm katzSchool of medicineRett syndrome foundationCompany or pharmatherDrug administrationDepartment of neurosciencesPharmather holdings ltdNeither the canadian securities exchangeCase western reserve universityRegulation services providerMother holdingsOrphan drug designationRett syndromeStatus epilepticus

PharmaTher Holdings Submits for FDA Orphan Drug Designation for Ketamine to Treat Rett Syndrome

PharmaTher Holdings Submits for FDA Orphan Drug Designation for Ketamine to Treat Rett Syndrome
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesFabio chianelliDavidm katzSchool of medicineRett syndrome foundationCompany or pharmatherRisk factors in companyDrug administrationDepartment of neurosciencesPharmather holdings ltdNeither the canadian securities exchangeCase western reserve universityRegulation services providerFabio chianellichief executive officerpharmather holdings ltd telWall streetMother holdings